Variations in the C3, C3a receptor, and C5 genes affect susceptibility to bronchial asthma
Authors:
- 27 July 2004
- journal article
- research article
- Published by Springer Nature in Human Genetics
- Vol. 115 (4) , 295-301
Abstract
Bronchial asthma (BA) is a common chronic inflammatory disease characterized by hyperresponsive airways, excess mucus production, eosinophil activation, and the production of IgE. The complement system plays an immunoregulatory role at the interface of innate and acquired immunities. Recent studies have provided evidence that C3, C3a receptor, and C5 are linked to airway hyperresponsiveness. To determine whether genetic variations in the genes of the complement system affect susceptibility to BA, we screened single nucleotide polymorphisms (SNPs) in C3, C5, the C3a receptor gene (C3AR1), and the C5a receptor gene (C5R1) and performed association studies in the Japanese population. The results of this SNP case-control study suggested an association between 4896C/T in the C3 gene and atopic childhood BA (P=0.0078) as well as adult BA (P=0.010). When patient data were stratified according to elevated total IgE levels, 4896C/T was more closely associated with adult BA (P=0.0016). A patient-only association study suggested that severity of childhood BA was associated with 1526G/A of the C3AR1 gene (P=0.0057). We identified a high-risk haplotype of the C3 gene for childhood (P=0.0021) and adult BA (P=0.0058) and a low-risk haplotype for adult BA (P=0.00011). We also identified a haplotype of the C5 gene that was protective against childhood BA (P=1.4×10−6) and adult BA (P=0.00063). These results suggest that the C3 and C5 pathways of the complement system play important roles in the pathogenesis of BA and that polymorphisms of these genes affect susceptibility to BA.Keywords
This publication has 29 references indexed in Scilit:
- A Polymorphism in the Human UGRP1 Gene Promoter That Regulates Transcription Is Associated with an Increased Risk of AsthmaThe American Journal of Human Genetics, 2002
- Complement Factors C3a and C5a are Increased in Bronchoalveolar Lavage Fluid after Segmental Allergen Provocation in Subjects with AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 2001
- Genetics of allergen-induced asthmaJournal of Allergy and Clinical Immunology, 2001
- Expression of the Complement Anaphylatoxin C3a and C5a Receptors on Bronchial Epithelial and Smooth Muscle Cells in Models of Sepsis and AsthmaThe Journal of Immunology, 2001
- Mutation detection by TaqMan-allele specific amplification: Application to molecular diagnosis of glycogen storage disease type Ia and medium-chain acyl-CoA dehydrogenase deficiencyHuman Mutation, 2000
- A genome-wide search for asthma susceptibility loci in ethnically diverse populationsNature Genetics, 1997
- Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice.Journal of Experimental Medicine, 1995
- Complement Peptides C3a- and C5a-Induced Mediator Release from Dissociated Human Skin Mast CellsJournal of Investigative Dermatology, 1994
- Guidelines for the diagnosis and management of asthma. National Heart, Lung, and Blood Institute. National Asthma Education Program. Expert Panel Report.1991
- THE VALIDITY OF APPROXIMATION METHODS FOR INTERVAL ESTIMATION OF THE ODDS RATIOAmerican Journal of Epidemiology, 1981